Cancer biomarkers circulating in body fluids can be used for diagnosis and treatment monitoring. However, current detection technology lacks the required sensitivity, limiting biomarker use in clinical applications.
Colorectal cancer is the second most common cancer in Europe with respect to incidence and mortality. Although early detection significantly improves outcome, screening compliance in the wider population is low due to the invasive nature of the colonoscopy procedure.
To facilitate prompt cancer diagnosis, the EU-funded ULTRAPLACAD project developed an in vitro platform for the detection of cancer nucleic acid and protein biomarkers circulating in the blood. “The idea was to improve biomarker detection sensitivity by a factor of 1 000, reduce the cost four-fold and the analysis time down to 1 hour,″ explains project coordinator Prof. Giuseppe Spoto of the University of Catania in Italy. The project team involved 13 partners across Europe with cross-disciplinary competencies, including pioneers in surface plasmon resonance.
Innovative technologies
The ULTRAPLACAD device has been designed to integrate a microfluidic circuit with functionalised nanostructure chips. It combines nanostructure-enhanced surface plasmon resonance imaging (NESPRI) and plasmon-enhanced fluorescence spectroscopy imaging (PEFSI). These two novel sensing technologies provide ultrasensitive detection and reduce the need for sample chemical modifications.
Chip design, surface architecture and chemical functionalisation of nanostructures facilitate the simultaneous measurement of multiple markers. For efficient nucleic acid detection, such as Ras mutations and miRNAs, specific probes have been synthesised. The disposable chips are mass produced through an automated fabrication process, which brings down the cost of the assay.
Traditionally, detection of minute amounts of DNA released in body fluids by tumour cells necessitates a pre-amplification step by polymerase chain reaction. The novelty of ULTRAPLACAD lies in the detection assays that do not require enzymatic amplification of DNA in liquid biopsies, thereby avoiding potential errors.
A bimodal reader for NESPRI and PEFSI technologies makes the ULTRAPLACAD device unique and improves the overall detection process even further. As Dr Spoto emphasises “the main advantage of the device is that it can detect both nucleic acids and protein using one single equipment operating with disposable chips.″
The ULTRAPLACAD prototype has been validated using animal models and samples from colorectal cancer patients. Results demonstrate that the sensitivity of the device exceeds conventional detection platforms and the whole assay is faster and simpler in its implementation.
The future of ULTRAPLACAD
Undoubtedly, the combined detection of cancer DNA sequences and selected tumour autoantibodies provide an effective cancer detection approach. ULTRAPLACAD offers a unique platform that can detect both DNA and protein cancer biomarkers, simplifying the process of diagnosis and patient follow-up.
Considering the limitations of existing colorectal cancer screening choices, ULTRAPLACAD offers a non-invasive alternative solution for average-risk asymptomatic people. As such, it will reduce the number of invasive procedures, cut down healthcare costs, and improve patient compliance and management.
Although the platform was specifically fabricated for early diagnosis and prognosis of colorectal cancer, its application can extend to other types of cancer. Long-term, it is also expected to determine the molecular heterogeneity of individual tumours, helping disease stratification and personalised therapy. In view of the future, Prof. Spoto envisages “the ULTRAPLACAD device will contribute to revolutionise molecular diagnosis of cancer and make a difference in cancer care.″
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
